Table 3.
Median values for the SF-36 domains and QUALEFFO-41 domains in the study groups at baseline and at the 6-month follow-up
| Median Baseline/Median 6 months/P Value* |
|||
|---|---|---|---|
| Controls n=37 | Spinal Orthosis n=38 | Exercise n=38 | |
| SF-36 | |||
| Physical function | 60/63/P=.22† | 50/45/P=.52† | 65/68/P=.25† |
| Role physical | 25/38/P=.79† | 12.5/0/P=.47† | 50/50/P=.63† |
| Bodily pain | 41/46/P=.95† | 41/41P=.29† | 47/51/P=.76† |
| General health | 52/54/P=.71† | 50/52/P=.66† | 55/62/P=.17† |
| Vitality | 50/60/P=.14† | 50/40/P=.14† | 55/58/P=.94† |
| Social function | 75/88/P=.41† | 63/63/P=.19† | 88/75/P=.06† |
| Role emotional | 67/83/P=.86† | 100/33/P=.03† | 100/67/P=.001† |
| Mental health | 72/80/P=.62† | 68/76/P=.29† | 80/80/P=.85† |
| PCS | 34/32/P=.54† | 31/31/P=.23† | 38/41/P=.05† |
| MCS | 47/51/P=.91† | 48/44/P=.04† | 52/48/P=.05† |
| QUALEFFO-41 | |||
| Pain | 60/53/P=.47† | 60/55/P=.09‡(P=.002) | 43/35/P=.25† |
| ADL | 13/9/P=.22† | 19/19/P=.11† | 13/6/ P=.98† |
| Jobs | 25/25/P=.22† | 40/35/P=.81† | 20/18/P=.17† |
| Mobility | 28/20/P=.03† | 28/31/P=.97† | 19/19/P=.89† |
| Social function | 33/38/P=.27†(P=.02) | 46/45/P=.11† | 32/46/P=.90† |
| General health | 58/50/P=.67† | 58/58/P=.92† | 50/46/P=.26† |
| Mental function | 36/36/P=.28† | 39/39/P=.58† | 33/32/P=.75† |
| Total score | 36/33/P=.23† | 40/37/P=.86† | 33/31/P=.97† |
NOTE. In the QUALEFFO-41, zero indicates the best and 100 the worst possible QoL. In the SF-36, zero indicates the worst possible and 100 the best QoL.
Abbreviations: ADL, activities of daily living; PCS, physical component summary; MCS, mental component summary index.
⁎
Wilcoxon signed rank test.
†
Not significant (P>.01) at 3 months either.
‡
Significant (P<.01) at 3 months.